Huijun Huang

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College
Tianjin, 300020, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Micheliolide exerts effects in myeloproliferative neoplasms through inhibiting STAT3/5 phosphorylation via covalent binding to STAT3/5 proteins.

Micheliolide exerts effects in myeloproliferative neoplasms through inhibiting STAT3/5 phosphorylation via covalent binding to STAT3/5 proteins.

Journal: Blood science (Baltimore, Md.)

Published: April 16, 2023

Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy.

Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy.

Journal: The New England journal of medicine

Published: May 25, 2022

ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms.

ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms.

Journal: Haematologica

Published: November 07, 2021

Conventional interferon-α 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center.

Conventional interferon-α 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center.

Journal: Haematologica

Published: September 24, 2021

Is race important in genomic classification of hematological neoplasms?

Is race important in genomic classification of hematological neoplasms?

Journal: Hematological oncology

Published: August 15, 2021

RBC distribution width predicts thrombosis risk in polycythemia vera.

RBC distribution width predicts thrombosis risk in polycythemia vera.

Journal: Leukemia

Published: July 07, 2021

Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.

Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.

Journal: Blood cancer journal

Published: July 02, 2021

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.

Journal: Experimental hematology & oncology

Published: February 17, 2021

Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre.

Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre.

Journal: Blood cancer journal

Published: April 23, 2020

Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia.

Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia.

Journal: British journal of haematology

Published: December 28, 2019

Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome.

Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome.

Journal: Leukemia & lymphoma

Published: May 07, 2019

Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.

Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.

Journal: British journal of haematology

Published: March 06, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026